106 related articles for article (PubMed ID: 7586929)
1. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine.
Hulsman JA; Rentmeester TW; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Radwanski E; Mojaverian P; Lin CC; Nezamis J
Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929
[TBL] [Abstract][Full Text] [Related]
2. Effects of felbamate on the pharmacokinetics of phenobarbital.
Reidenberg P; Glue P; Banfield CR; Colucci RD; Meehan JW; Radwanski E; Mojavarian P; Lin CC; Nezamis J; Guillaume M
Clin Pharmacol Ther; 1995 Sep; 58(3):279-87. PubMed ID: 7554701
[TBL] [Abstract][Full Text] [Related]
3. Effect of felbamate on the pharmacokinetics of lamotrigine.
Colucci R; Glue P; Holt B; Banfield C; Reidenberg P; Meehan JW; Pai S; Nomeir A; Lim J; Lin CC; Affrime MB
J Clin Pharmacol; 1996 Jul; 36(7):634-8. PubMed ID: 8844446
[TBL] [Abstract][Full Text] [Related]
4. Effect of felbamate on carbamazepine and its major metabolites.
Wagner ML; Remmel RP; Graves NM; Leppik IE
Clin Pharmacol Ther; 1993 May; 53(5):536-43. PubMed ID: 8491065
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.
Glue P; Banfield CR; Perhach JL; Mather GG; Racha JK; Levy RH
Clin Pharmacokinet; 1997 Sep; 33(3):214-24. PubMed ID: 9314612
[TBL] [Abstract][Full Text] [Related]
6. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.
Saano V; Glue P; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Haring P; Radwanski E; Nomeir A; Lin CC
Clin Pharmacol Ther; 1995 Nov; 58(5):523-31. PubMed ID: 7586946
[TBL] [Abstract][Full Text] [Related]
7. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ
Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.
Clemens PL; Cloyd JC; Kriel RL; Remmel RP
Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interaction studies between felbamate and vigabatrin.
Reidenberg P; Glue P; Banfield C; Colucci R; Meehan J; Rey E; Radwanski E; Nomeir A; Lim J; Lin C
Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic drug interactions in children taking oxcarbazepine.
Sallas WM; Milosavljev S; D'souza J; Hossain M
Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224
[TBL] [Abstract][Full Text] [Related]
11. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of oxcarbazepine.
May TW; Korn-Merker E; Rambeck B
Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
[TBL] [Abstract][Full Text] [Related]
13. Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
Theis JG; Sidhu J; Palmer J; Job S; Bullman J; Ascher J
Neuropsychopharmacology; 2005 Dec; 30(12):2269-74. PubMed ID: 16052246
[TBL] [Abstract][Full Text] [Related]
14. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
Rouan MC; Lecaillon JB; Godbillon J; Menard F; Darragon T; Meyer P; Kourilsky O; Hillion D; Aldigier JC; Jungers P
Eur J Clin Pharmacol; 1994; 47(2):161-7. PubMed ID: 7859804
[TBL] [Abstract][Full Text] [Related]
15. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
Graves NM; Holmes GB; Fuerst RH; Leppik IE
Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
[TBL] [Abstract][Full Text] [Related]
16. Felbamate: a new antiepileptic drug.
Wagner ML
Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy.
Sachdeo RC; Narang-Sachdeo S; Montgomery PA; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
J Clin Pharmacol; 1998 Feb; 38(2):184-90. PubMed ID: 9549651
[TBL] [Abstract][Full Text] [Related]
18. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
Mecarelli O; Vicenzini E; Pulitano P; Vanacore N; Romolo FS; Di Piero V; Lenzi GL; Accornero N
Ann Pharmacother; 2004 Nov; 38(11):1816-22. PubMed ID: 15367726
[TBL] [Abstract][Full Text] [Related]
19. Single and multiple dose pharmacokinetics of felbamate in the elderly.
Richens A; Banfield CR; Salfi M; Nomeir A; Lin CC; Jensen P; Affrime MB; Glue P
Br J Clin Pharmacol; 1997 Aug; 44(2):129-34. PubMed ID: 9278196
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modeling to clinical trials.
Graves NM; Ludden TM; Holmes GB; Fuerst RH; Leppik IE
Pharmacotherapy; 1989; 9(6):372-6. PubMed ID: 2694113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
